Resident macrophages activate the expression of folate receptor β (FR-β), and FR-β transcription levels are elevated in both NASH fat and non-fat samples [30], suggesting that FRs may be used for drugs that directly target the liver. The gene discussed is FOLR2; the disease is metabolic dysfunction-associated steatohepatitis.